Pages that link to "Q53035057"
Jump to navigation
Jump to search
The following pages link to Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo. (Q53035057):
Displaying 50 items.
- Galantamine for Alzheimer's disease and mild cognitive impairment (Q24244773) (← links)
- Galantamine for Alzheimer's disease (Q24246158) (← links)
- The pharmacological landscape and therapeutic potential of serine hydrolases (Q26995817) (← links)
- Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs (Q27618667) (← links)
- Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution (Q27620782) (← links)
- Galantamine: a review of its use in Alzheimer's disease (Q31754077) (← links)
- Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease (Q32077293) (← links)
- Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease (Q33637687) (← links)
- Review of the acetylcholinesterase inhibitor galanthamine (Q34075135) (← links)
- Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease (Q34144550) (← links)
- Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease (Q34327769) (← links)
- Current status and new developments with galantamine in the treatment of Alzheimer's disease (Q34515591) (← links)
- Pharmacologic treatments of dementia (Q34779344) (← links)
- Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents (Q34999015) (← links)
- Nicotinic cholinergic modulation: galantamine as a prototype. (Q35025118) (← links)
- Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease. (Q35066849) (← links)
- A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease (Q35236228) (← links)
- Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease (Q35538846) (← links)
- Clinical pharmacokinetics of galantamine (Q35607538) (← links)
- Pharmacotherapeutic approaches to the treatment of Alzheimer's disease (Q35818897) (← links)
- Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation (Q36237626) (← links)
- Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study (Q36247233) (← links)
- An update on the pharmacology of galantamine (Q37016107) (← links)
- Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease (Q37092481) (← links)
- Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine (Q37444415) (← links)
- Donepezil in the treatment of patients with Alzheimer's disease (Q37464161) (← links)
- A review on cholinesterase inhibitors for Alzheimer's disease (Q38084168) (← links)
- A fluorescence assay for measuring acetylcholinesterase activity in rat blood and a human neuroblastoma cell line (SH-SY5Y). (Q38854196) (← links)
- Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells (Q39694999) (← links)
- Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. (Q40454009) (← links)
- Galanthamine (Q41119615) (← links)
- Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans. (Q43503382) (← links)
- Cytotoxic alkaloids and a flavan from the bulbs of Crinum asiaticum var. japonicum (Q43738703) (← links)
- Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats (Q43804284) (← links)
- Inhibition of acetylcholinesterase activity by essential oil from Citrus paradisi (Q43891248) (← links)
- Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. (Q44149343) (← links)
- A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. (Q44193387) (← links)
- Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors (Q44340367) (← links)
- Synthesis and structure-activity relationships of open D-Ring galanthamine analogues (Q44489597) (← links)
- A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease (Q44522002) (← links)
- A nonlinear mixed effects IVIVC model for multi-release drug delivery systems. (Q46379979) (← links)
- Free radical scavenging and antiacetylcholinesterase activities of Origanum majorana L. essential oil. (Q46569804) (← links)
- Transcriptome and metabolome profiling of Narcissus pseudonarcissus 'King Alfred' reveal components of Amaryllidaceae alkaloid metabolism (Q47127397) (← links)
- Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice (Q48731865) (← links)
- Improved thin-layer chromatography bioautographic assay for the detection of actylcholinesterase inhibitors in plants (Q50279580) (← links)
- Acetylcholinesterase-inhibitors in the treatment of autistic disorders (Q50344956) (← links)
- Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease (Q50627263) (← links)
- Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques. (Q51036690) (← links)
- Galanthamine in Alzheimer's disease : a new alternative to tacrine? (Q51548277) (← links)
- Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease. (Q51974873) (← links)